news

Dr. Margot McBride’s Osteoporosis Story

Dr. Margot McBride is an amputee suffering from severe osteoporosis who is also in remission from Cushing’s disease. Margot believes that if her low bone mass was diagnosed earlier her osteoporosis would be far less severe today. Margot’s Background Dr. Margot McBride is a research radiographer who recently joined IBEX as a Clinical Advisor. Her…

news

IBEX’s Ground-Breaking Bone Health Study Published in the BMJ

Findings from a clinical study investigating IBEX Trueview® as a predictor of bone health were recently published in the British Medical Journal, marking a major milestone for IBEX. Using advanced physics modelling and AI methods, the Trueview software returns an accurate measure of bone health from standard DR scans taken for other clinical purposes. This…

news

A New Approach for Identifying Fracture Risk from a Standard Digital Radiograph

IBEX Trueview® software uses physics modelling and AI methods to return an accurate measurement of bone health from standard DR scans. The software aims to improve patient outcomes and reduce healthcare costs through increased identification of patients at risk of fracture. Opportunistic Fracture Risk Prediction Trueview’s output is correlated to DXA-derived areal bone mineral density (aBMD) and can therefore be combined with other…

news

Gridless Scatter Correction for 2D and 3D Mammography

Cutting-edge IBEX Trueview® software delivers diagnostic images without a grid to enable up to 25% dose reduction in 2D and 3D mammography. Effective for all breast compressions, this technology offers improved image contrast in FFDM, DBT, and synthetic 2D images, leading to: Improved sensitivity and specificityFewer false positivesReduced mechanical complexity and lower system costsSimplified workflow Proven performance in SDNR testing Trueview software-based scatter…

news

Reducing costs and improving quality of life through earlier detection of osteoporosis

Health economics modelling shows that adoption of IBEX Trueview​® software for the early diagnosis of osteoporosis could save £9.2 million in costs and generate 1,650 QALYs over 20 years for a typical NHS trust. Tackling the Osteoporosis Crisis Using advanced physics modelling and AI methods, IBEX Trueview® turns standard X-rays into an opportunity for early diagnosis of osteoporosis, a disease that currently affects…

news

IBEX secures £3.25m funding to transform osteoporosis diagnosis and care

IBEX Innovations Limited, the UK-based provider of advanced medical imaging software, is delighted to announce the completion of a £3.25m equity financing round from existing venture and corporate investors. The funding will be used to drive market adoption of the innovative IBEX Trueview® software platform across medical X-ray imaging applications and to complete commercialisation of…

news

Simulated Clinical Study Reveals Trueview Accurately Predicts Wrist Bone Health

IBEX recently completed a simulated clinical study, where a population of 30 wrist X-rays were synthetically generated for a population with bone health ranging from normal to severe osteoporosis. The IBEX Trueview Bone Health Classifier returns a measure of a patient’s bone health from a standard digital radiograph, without the need for any specialist hardware such as DXA. Synthetic…

news

IBEX showcases state-of-the-art scatter correction and bone classification products at ECR 2021

ECR 2021 is now underway and IBEX are excited to be showcasing revolutionary Trueview gridless scatter correction technology for DR, CBCT, and Mammography. Although we can’t be in the beautiful city of Vienna in person, IBEX is delighted to be sharing the latest developments, including fast scatter correction, bone health classification for DR, and synthetic…

news

A New £4bn Market for DR Manufacturers

IBEX is pleased to help spread the word of poor bone health, and, most importantly, offer a solution for earlier and more widespread detection of this deadly disease. Osteoporosis: a £50bn Global Problem Osteoporosis may not have the same visibility as breast cancer, but it is a massive global healthcare problem with a financial cost…